Beni B. Wolf

10.6k total citations · 5 hit papers
53 papers, 7.6k citations indexed

About

Beni B. Wolf is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Beni B. Wolf has authored 53 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 20 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Beni B. Wolf's work include Cell death mechanisms and regulation (12 papers), Lung Cancer Treatments and Mutations (9 papers) and Peptidase Inhibition and Analysis (8 papers). Beni B. Wolf is often cited by papers focused on Cell death mechanisms and regulation (12 papers), Lung Cancer Treatments and Mutations (9 papers) and Peptidase Inhibition and Analysis (8 papers). Beni B. Wolf collaborates with scholars based in United States, United Kingdom and Canada. Beni B. Wolf's co-authors include Douglas R. Green, Gerald M. Cohen, John C. Reed, Helen M. Beere, Donald D. Newmeyer, Ruth M. Kluck, Tomomi Kuwana, Steven L. Gonias, Pankaj Tailor and Mary T. Harte and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Beni B. Wolf

52 papers receiving 7.4k citations

Hit Papers

Ordering the Cytochrome c–initiated Caspase Cascade: Hier... 1998 2026 2007 2016 1999 2000 1999 1999 1998 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent Manner
    1999 1.6k citations Ruth M. Kluck, Beni B. Wolf et al. profile →
  2. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome
    2000 1.3k citations Helen M. Beere, Beni B. Wolf et al. profile →
  3. Suicidal Tendencies: Apoptotic Cell Death by Caspase Family Proteinases
    1999 813 citations Beni B. Wolf, Douglas R. Green Journal of Biological Chemistry profile →
  4. Distinct Caspase Cascades Are Initiated in Receptor-mediated and Chemical-induced Apoptosis
    1999 748 citations Beni B. Wolf, Douglas R. Green et al. Journal of Biological Chemistry profile →
  5. Pro-caspase-3 Is a Major Physiologic Target of Caspase-8
    1998 649 citations Henning R. Stennicke, Juliane M. Jürgensmeier et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beni B. Wolf United States 26 5.3k 1.3k 1.2k 893 840 53 7.6k
Henning R. Stennicke Denmark 29 6.6k 1.2× 1.5k 1.1× 1.5k 1.2× 938 1.1× 909 1.1× 56 8.9k
Christoph Borner Germany 50 6.1k 1.2× 1.3k 1.0× 1.6k 1.3× 715 0.8× 959 1.1× 119 8.8k
Deepak Nijhawan United States 19 6.8k 1.3× 1.4k 1.1× 1.2k 1.0× 955 1.1× 749 0.9× 28 9.1k
Reiner U. Jänicke Germany 37 6.5k 1.2× 2.0k 1.5× 1.5k 1.3× 1.1k 1.3× 795 0.9× 68 9.9k
Atan Gross Israel 25 7.0k 1.3× 1.4k 1.1× 1.5k 1.2× 999 1.1× 646 0.8× 32 8.8k
Masato Enari Japan 32 7.1k 1.3× 1.3k 1.0× 1.7k 1.4× 850 1.0× 599 0.7× 50 8.8k
Tomomi Kuwana United States 28 7.9k 1.5× 1.6k 1.2× 1.2k 1.0× 869 1.0× 1.0k 1.2× 46 10.0k
Hubert Hug Germany 28 4.8k 0.9× 1.3k 1.0× 1.5k 1.3× 710 0.8× 590 0.7× 42 6.7k
François M. Vallette France 51 5.7k 1.1× 1.3k 1.0× 864 0.7× 1.5k 1.6× 529 0.6× 178 9.2k
Nigel J. Waterhouse Australia 41 4.8k 0.9× 1.2k 0.9× 1.7k 1.4× 690 0.8× 627 0.7× 76 7.5k

Countries citing papers authored by Beni B. Wolf

Since Specialization
Citations

This map shows the geographic impact of Beni B. Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beni B. Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beni B. Wolf more than expected).

Fields of papers citing papers by Beni B. Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beni B. Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beni B. Wolf. The network helps show where Beni B. Wolf may publish in the future.

Co-authorship network of co-authors of Beni B. Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Beni B. Wolf. A scholar is included among the top collaborators of Beni B. Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beni B. Wolf. Beni B. Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Melissa L., Beni B. Wolf, Judy S. Wang, et al.. (2024). First Results of Migoprotafib, a Potent and Highly Selective Src Homology-2 Domain–Containing Phosphatase 2 Inhibitor in Patients with Advanced Solid Tumors. Molecular Cancer Therapeutics. 24(3). 384–391.
2.
Varkaris, Andreas, Komal Jhaveri, Cesar A. Perez, et al.. (2023). Abstract CT017: Pan-mutant and isoform selective PI3Kα inhibitor, RLY-2608, demonstrates selective targeting in a first-in-human study of PIK3CA-mutant solid tumor patients, ReDiscover trial. Cancer Research. 83(8_Supplement). CT017–CT017. 5 indexed citations
3.
Piotrowska, Zofia, Hideko Isozaki, Jochen K. Lennerz, et al.. (2018). MA26.03 Activity of Osimertinib and the Selective RET Inhibitor BLU-667 in an EGFR-Mutant Patient with Acquired RET Rearrangement. Journal of Thoracic Oncology. 13(10). S451–S451. 1 indexed citations
4.
Sarker, Debashis, Teresa Macarulla, Thomas Yau, et al.. (2017). Phase 1 safety and clinical activity of BLU-554 in advanced hepatocellular carcinoma (HCC). Annals of Oncology. 28. v122–v122. 17 indexed citations
5.
Heinrich, Michael C., Robin L. Jones, Margaret von Mehren, et al.. (2017). Clinical activity of BLU-285 in advanced gastrointestinal stromal tumor (GIST).. Journal of Clinical Oncology. 35(15_suppl). 11011–11011. 15 indexed citations
6.
Kearns, Jeffrey D., Raghida A. Bukhalid, Mark Sevecka, et al.. (2015). Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic. Molecular Cancer Therapeutics. 14(7). 1625–1636. 46 indexed citations
7.
Wolf, Beni B., et al.. (2008). On The Edge of Validation – Cancer Protease Fibroblast Activation Protein. Mini-Reviews in Medicinal Chemistry. 8(7). 719–727. 29 indexed citations
8.
Burkhardt, Brant, Joshua R. Cook, Robert C. Young, & Beni B. Wolf. (2008). PDX-1 interaction and regulation of the Pancreatic Derived Factor (PANDER, FAM3B) promoter. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1779(10). 645–651. 19 indexed citations
9.
Quan, Clifford, Christian Wiesmann, Dan Sutherlin, et al.. (2006). Selective Inhibition of Fibroblast Activation Protein Protease Based on Dipeptide Substrate Specificity. Journal of Biological Chemistry. 281(11). 7437–7444. 1 indexed citations
10.
Zhou, Honglin, Denise M. Monack, Nobuhiko Kayagaki, et al.. (2005). Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation. The Journal of Experimental Medicine. 202(10). 1327–1332. 187 indexed citations
11.
Wolf, Beni B. & Douglas R. Green. (2002). Apoptosis: Letting Slip The Dogs Of War. Current Biology. 12(5). R177–R179. 36 indexed citations
12.
Wolf, Beni B., Martin Schüler, Wěi Li, et al.. (2001). Defective Cytochrome c-dependent Caspase Activation in Ovarian Cancer Cell Lines due to Diminished or Absent Apoptotic Protease Activating Factor-1 Activity. Journal of Biological Chemistry. 276(36). 34244–34251. 102 indexed citations
13.
Newmeyer, Donald D., Ella Bossy‐Wetzel, Ruth M. Kluck, et al.. (2000). Bcl-xL does not inhibit the function of Apaf-1. Cell Death and Differentiation. 7(4). 402–407. 71 indexed citations
14.
Wolf, Beni B. & Douglas R. Green. (1999). Suicidal Tendencies: Apoptotic Cell Death by Caspase Family Proteinases. Journal of Biological Chemistry. 274(29). 20049–20052. 813 indexed citations breakdown →
15.
Stennicke, Henning R., Juliane M. Jürgensmeier, Hwain Shin, et al.. (1998). Pro-caspase-3 Is a Major Physiologic Target of Caspase-8. Journal of Biological Chemistry. 273(42). 27084–27090. 649 indexed citations breakdown →
16.
17.
Gonias, Steven L., Jonathan LaMarre, Kendall P. Crookston, et al.. (1994). α2‐Macroglobulin and the α2‐Macroglobulin Receptor/LRP A Growth Regulatory Axisa. Annals of the New York Academy of Sciences. 737(1). 273–290. 70 indexed citations
18.
Wolf, Beni B. & Steven L. Gonias. (1994). Neurotrophin Binding to Human .alpha.2-Macroglobulin under Apparent Equilibrium Conditions. Biochemistry. 33(37). 11270–11277. 43 indexed citations
19.
20.
Wolf, Beni B., Günter Fischer, & A. Barth. (1978). [Kinetics of dipeptidyl-peptidase IV].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(3). 409–20. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henning R. Stennicke Breakdown of academic impact, for papers by Christoph Borner Breakdown of academic impact, for papers by Deepak Nijhawan Breakdown of academic impact, for papers by Reiner U. Jänicke Breakdown of academic impact, for papers by Atan Gross Breakdown of academic impact, for papers by Masato Enari Breakdown of academic impact, for papers by Tomomi Kuwana Breakdown of academic impact, for papers by Hubert Hug Breakdown of academic impact, for papers by François M. Vallette Breakdown of academic impact, for papers by Nigel J. Waterhouse
Rankless by CCL
2026